Press

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits.This is where we post all our press releases. If you are a journalist interested in learning more about the biotechnology sector, contact Ángel Luis Jiménez, our Communication Directorajimenez@asebio.com 

Search engine
Firma del acuerdo entre AseBio y FATE
AseBio and FATE sign an agreement to boost innovation in biotechnology, foodtech and agritech at national and European level
Agrifood · Food & feed · Agriculture
  • The agreement responds to the complementarity of objectives and lines of work between both organizations and reinforces AseBio’s commitment to sustainable agriculture and food innovation.
  • AseBio and FATE–Food&AgriTech Europe aim to consolidate a cooperation framework that promotes innovation, facilitates knowledge exchange and strengthens European leadership in the Foodtech and Agritech sectors.
AseBio
Científico analizando muestras de plantas
The European sector urges the EU to avoid new restrictions and to conclude a coherent, science-based agreement on NGTs
Climate change · Agrifood · Food & feed · Agriculture · Gene editing
  • The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New Genomic Techniques (NGTs) and the food and feed derived from them.
  • After months of negotiations, 25 European organizations have sent a letter to Parliament calling for the avoidance of unjustified new restrictions and for support of a final agreement consistent with the original proposal.
  • At AseBio, we fully endorse this joint letter, as the future of European agriculture and its competitiveness depends on having a proportionate, clear regulatory framework aligned with scientific evidence.
     
AseBio
Imagen que representa conexiones tecnológicas
Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of deep technologies
Healthcare · Access to innovation · Financing
  • The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities containing 13 concrete proposals to respond to the public consultation and guide the future Spanish Deep Technologies Strategy.
  • The aim of this document is to promote a specific regulatory framework that recognises these technologies as a strategic sector for the country’s technological autonomy and competitiveness, as well as measures to ensure the creation of coordinated ecosystems, integrated value chains, and economic instruments that complement scientific research and development.
AseBio
Speakers at the event organized by AseBio within the framework of World Antimicrobial Awareness Week
Biotechnology, key to curbing antimicrobial resistance and strengthening European health security
Healthcare · Antibiotic resistance · Animal health
  • In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, including 35,000 annual deaths in Europe and around 4,000 in Spain.
  • The WHO warns of a sustained increase in resistant infections—one in six in 2023—especially caused by multidrug-resistant bacteria such as Escherichia coli and Klebsiella pneumoniae.
  • Biotechnology is emerging as a strategic ally to develop new antibiotics, therapies, vaccines, and rapid diagnostic tools, as well as to apply artificial intelligence and large-scale data analysis in epidemiological surveillance.
AseBio
Dr. Luis Montuenga, coordinador del Programa de Tumores del Tracto Respiratorio del área de cáncer del CIBER (CIBERONC)
A 20% increase in survival through early diagnosis: biotechnology accelerates change in the fight against the deadliest tumour
Healthcare
  • Low-dose CT screening can significantly reduce mortality and increase patient survival by around 20%, according to international scientific evidence
  • Biotechnology is revolutionising lung cancer diagnosis and treatment through technologies such as next-generation sequencing, liquid biopsy, spatial transcriptomics and single-cell analysis.
  • Spain continues to make progress in translational research thanks to groups like CIBERONC, although major challenges remain, including therapeutic resistance, tumour heterogeneity and the absence of a population-wide screening programme.
AseBio
Paciente que tiene psoriasis
Innovation, research, and the future: biotechnology sets the course for psoriasis treatment
Healthcare · Access to innovation · Innovative drugs
  • Biotechnology enables the development of more effective and personalized treatments for chronic inflammatory diseases such as psoriasis, improving the quality of life for millions of people.
  • Inhibitec Anticuerpos, an AseBio member company, is researching a new therapeutic target called BAMBI, with promising results in both the skin and joint manifestations of the disease.
  • Collaboration with patients and international foundations drives research that is closer, more human, and focused on the real needs of those living with psoriasis.
AseBio
Detalle de una planta en un campo de cultivo
Biotechnology emerges as Spain’s key tool against climate change: nearly 600 solutions developed to drive the green transition
Climate change · Agrifood · Food & feed · Agriculture
  • In the face of climate change, ecosystem degradation, and population growth, moving toward a sustainable economic model is urgent. The green transition stands as the essential roadmap, with biotechnology as the engine of change, according to Spain’s 2050 Strategy.
  • At AseBio, our Sustainability Commission has prepared the report “Biotechnology Applied to the Green Transition,” which analyzes the solutions, areas of action, distribution, and challenges of our member companies to promote a more sustainable future.
  • The report compiles 587 solutions from 66 companies and 20 organizations contributing to Spain’s green transition, organized into 27 activity areas across food innovation, bioprocesses, sustainable agriculture, and bioproducts.
AseBio
laboratorio
Biotechnology: a key ally in the fight against breast cancer
Healthcare
  • Biotechnological innovation is transforming treatments toward safer, more effective and personalized options.
  • Nanotechnology-based therapies mark a new era in oncology treatment.
  • According to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected in women.
AseBio
Agricultor en un vivero
Biotechnology: A key ally in the challenge of feeding 10 billion people
Climate change · Agrifood · Food & feed · Agriculture
  • Biotechnology drives solutions to optimize the use of natural resources, reduce emissions, and advance toward a circular economy.
  • The development of alternative proteins — plant-based, microbial, or cultivated — stands out as one of the most promising pathways to ensure future food security.
  • Collaboration among technology centers, industry, and public administrations will be essential to accelerate the transition toward sustainable food systems.
AseBio